The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
about
GSK-3: tricks of the trade for a multi-tasking kinaseThe role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisThe protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation and increases sarcoplasmic/endoplasmic reticulum calcium ATPase 2 levelsA novel mass spectrometry-based assay for GSK-3beta activity.The Rationale for Insulin Therapy in Alzheimer's DiseaseInhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8Metabolic consequences of high-fat diet are attenuated by suppression of HIF-1α.Trace elements in glucometabolic disorders: an update.Therapeutic Approaches for Preserving or Restoring Pancreatic β-Cell Function and Mass.Treatment of non-insulin-dependent diabetes mellitus.Liver-specific deletion of Ppp2cα enhances glucose metabolism and insulin sensitivity.Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.Disruption of circadian rhythmicity and suprachiasmatic action potential frequency in a mouse model with constitutive activation of glycogen synthase kinase 3.Antiobesity activity of a sphingosine 1-phosphate analogue FTY720 observed in adipocytes and obese mouse model.Inositol pyrophosphates as mammalian cell signalsCigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes.A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.PKCδ phosphorylation is an upstream event of GSK3 inactivation-mediated ROS generation in TGF-β1-induced senescence.Effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia in the frequently sampled intravenous glucose tolerance test.SLIT2 inhibits cell migration in colorectal cancer through the AKT-GSK3β signaling pathway.Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.Phospholipase C-independent activation of glycogen synthase kinase-3beta and C-terminal Src kinase by Galphaq.Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells.Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain.Identification of genes contributing to the obese yellow Avy phenotype: caloric restriction, genotype, diet x genotype interactions.The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells.Glycogen synthase kinase-3 regulates production of amyloid-β peptides and tau phosphorylation in diabetic rat brain.
P2860
Q24624069-20D02005-6F68-465C-BD8D-5B99DF83A91AQ24651407-DB990BDB-1733-496A-BEF6-5EBD85940A74Q24678277-ABFB51F0-1415-4C52-A4EF-5FA48DDD6407Q25257396-BEC5CC7F-D4FC-4905-BE85-EA8CEEC25D1EQ26744834-840015D9-E41A-4779-B0AD-4430B02EA937Q28476019-37A32D3D-104E-42E8-A3A4-B0C3BA8C3093Q34437691-6E5F2EFE-6427-4FB7-BCB1-E24627779EBFQ34504189-69A811A8-0714-4846-ACC7-E7A1FE4CA625Q34750027-86FD1DA1-6427-48A2-B549-D99E73746CD6Q35094680-D939B62E-DEB4-485E-9425-0B00EEF1D41EQ35598541-62108414-559E-46DE-AAF0-5188C987FC8CQ35610595-B37F5EF6-15D7-4083-B40C-3ABC7A7188C7Q35770186-0882053D-57D2-444E-9EF5-2EEA804DB216Q36374243-0F52FFB6-B38B-4D01-ADDC-6870E8BA1114Q36374498-702F604A-6727-4A87-AD86-1293A592831FQ36886772-B87D4FFA-F1C2-4A18-BBC2-D7018AF509B7Q37088228-4D56D7FE-DEAD-42F5-8430-0712069BCD9CQ38194549-51E55F95-1DC9-429B-8221-EDE311D3366EQ38885892-1F06FC1B-F0BA-4E19-93CB-0D8825A1B398Q38985955-BA78205C-94BE-44B1-8182-AB70527F879FQ39011220-4752DE41-2633-4A70-8BF3-AD326D672A8FQ39211407-757AD6A7-D124-42B0-930B-61B59EA2A4BBQ39937420-99552764-A9D3-4E8A-B57C-419FE67DA622Q40625747-C3BDD009-2CB5-4BA0-9DED-C626E2441B84Q41167448-6B38076E-0124-425B-BCDB-8D66B65D4872Q42053859-21BAAC7D-A6BF-402A-921A-D0D29EC0488DQ46207304-B9B62F01-5F41-4A81-B487-265F1CD68341Q47322400-CAFC606F-3102-4F35-BD29-FD0264DD3E87Q53466284-5A4EDD1B-1112-4AB4-8953-8419AC92A8A3
P2860
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
@ast
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
@en
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
@nl
type
label
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
@ast
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
@en
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
@nl
prefLabel
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
@ast
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
@en
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
@nl
P2860
P356
P1476
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
@en
P2093
Oksana Kaidanovich
P2860
P304
P356
10.1517/14728222.6.5.555
P407
P577
2002-10-01T00:00:00Z